- A two-round modified Delphi consensus study of 35 experts, 33 of them anesthesiologists from 17 countries, addressed adults with recent concussion having noncardiac extracranial surgery.
- The panel rated statements on a five-point Likert scale, with consensus defined a priori as at least 75% agreement and strong consensus as at least 85%.
- Of 16 Round 2 statements, 13 reached consensus, including unanimous agreement on preoperative screening and avoiding hypoxemia, hypotension, and marked hypertension, and strong consensus (97%) for generally deferring elective surgery until symptoms resolve.
- Consensus was not reached for regional or monitored anesthesia care over general anesthesia (74%), EEG-guided depth monitoring (73%), or cautious long-acting neuraxial opioid use (69%); the authors describe the output as an expert-informed framework, not an evidence-based guideline.
Neuro
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Systematic review and meta-analysis of five placebo-controlled RCTs (335 participants) testing perioperative pregabalin in adults undergoing elective lumbar spine surgery.
- Pregabalin was compared with placebo, with the primary outcome being pain intensity at 3 months, pooled across four trials (275 participants).
- Pregabalin did not reduce 3-month pain intensity (SMD 0.03, 95% CI -0.41 to 0.47; I² 69%; low certainty).
- Functional disability was lower with pregabalin (SMD -0.51, 95% CI -0.86 to -0.16), but the differences fell below minimal important change thresholds, with very low certainty.
- Ambidirectional cohort of 77 children aged 9-11, with or without prior surgical general anesthesia exposure, tested on a cognitive battery.
- Eight measures covered inhibitory control, cognitive flexibility, working memory, and visuo-spatial attention, analyzed with mixed-effects and exploratory latent profile models.
- No overall exposure effect on executive function (χ²(1)=.01, p=.92), but exposure was linked to lower odds of the Efficient profile (OR 0.71, 95% CI [0.705, 0.710], p<.001).
- Exposed children showed higher global-local precedence (estimate 0.53, 95% CI [0.04, 1.01], p=.036), which the authors describe as a possible post-operative phenotype.
- A Bayesian systematic review and meta-analysis of 54 studies, including 367,896 critically ill adults, examined new-onset atrial fibrillation in general ICUs and high-dependency units.
- It compared post-discharge systemic thromboembolism in patients with and without new-onset atrial fibrillation, with follow-up ranging from 1.5 months to 5 years.
- Pooled NOAF incidence was 10.6% (95% CrI 8.6-12.9%), and post-discharge thromboembolism risk was 7.1% (95% CrI 4.5-11.0%). Relative risk was 1.94 (95% CrI 1.23-3.29) across six studies, rising to 2.01 with adjustment.
- Anticoagulation use was low, at 32.9% in-hospital and 35.9% post-discharge, and 23.9% of patients with NOAF were later diagnosed with atrial fibrillation.
- Single-center, randomized, double-blind, placebo-controlled pilot trial of 100 critically ill adults with CAM-ICU-confirmed delirium in surgical and trauma ICUs.
- Patients received 2 mg guanfacine or matching placebo nightly for up to 14 days, or until ICU discharge or delirium resolution.
- Median delirium and coma-free days were 2 (IQR 0-6) with guanfacine versus 1 (IQR 0-4) with placebo (p = 0.02) in unadjusted analyses, but not significant after adjustment.
- Feasibility targets were mostly met, with 100% adherence, retention, and data completeness, though COVID-19 limited recruitment to 0.9 patients/week; authors judge the signal worth a multicenter trial.
- This methods paper uses data from the MENDS trial to examine composite endpoints for critical care delirium trials.
- It evaluates two existing composites: delirium- and coma-free days, and a ranked endpoint that treats death as worst and orders delirium- and coma-free days among survivors.
- The authors describe how to define treatment effects on each composite, assess their clinical interpretability, and visualize how effects accumulate over follow-up.
- They provide practical recommendations for composite endpoints that could extend to other randomized trials using similar endpoints.
- Multicenter prospective cohort of 480 adults with sepsis plus shock and/or acute respiratory failure, enrolled in medical and surgical ICUs in Nashville, TN.
- Plasma ccf-mtDNA was measured on study days 1, 3, and 5 and related to delirium and coma; no intervention was given.
- Higher ccf-mtDNA was associated with lower odds of delirium (OR 0.93, 95% CI 0.86-0.99; p = 0.048), but not with coma or 3- or 12-month cognition.
- Mortality association was marginal (HR 1.09, 95% CI 0.99-1.20; p = 0.08); the authors urge cautious interpretation until the finding is replicated.
- This scoping review of 130 studies, mostly observational cohorts (83.8%), mapped literature on chronic preoperative benzodiazepine use and perioperative outcomes.
- Chronic use was defined inconsistently, ranging from 1 month to over 1 year before surgery, and duration was not systematically defined in 47.7% of studies.
- Postoperative opioid use (40.8% of studies) and delirium or cognitive impairment (14.6%) were the most examined outcomes, with most reporting adverse associations.
- The authors conclude chronic use is a clinically relevant but inconsistently defined exposure, and that causal inference is not possible without risk-of-bias assessment and prospective studies.
- In a prospective multicentre observational study of 2442 adult surgical patients at 43 Spanish hospitals, 1899 completed 1-year telephone follow-up.
- The exposure was postoperative delirium within 48 hours, screened with CAM, CAM-ICU or the telephone-administered 4AT depending on setting.
- Delirium was independently associated with a 4.60-point higher WHODAS 2.0 score at 1 year (95% CI 1.57 to 7.64, P = 0.003), and with institutionalisation (OR 2.5, 95% CI 1.07 to 5.84, P = 0.03).
- Mortality was 16.7% versus 3.1% (P < 0.001), and the authors conclude that delirium is a key perioperative complication that supports prevention and structured long-term follow-up.
- This state-of-the-art review covers delirium epidemiology, mechanisms, diagnosis, prevention and treatment across cardiovascular medicine, drawing on interdisciplinary expert input.
- It identifies risk factors such as advanced age, baseline cognitive impairment, cerebrovascular disease, longer operative times, complications and systemic inflammation.
- Non-pharmacological multicomponent prevention is described as strongly supported, while preventive pharmacologic use remains controversial; dexmedetomidine is noted for ICU settings.
- The authors conclude that systematic risk assessment and multimodal prevention should be standard care, with more high-quality studies needed for cardiovascular-specific guidelines.
- Scoping review (PRISMA-ScR) of 48 included studies from 1,342 screened, mostly US-based and retrospective (43/48).
- Included studies examined GLP-1 receptor agonist exposure in adults with spinal, intracranial, or cerebrovascular disease, grouped into three themes.
- Spinal fusion studies repeatedly linked perioperative exposure to lower pseudarthrosis, though some reported more postoperative complications; IIH studies linked it to lower papilledema and shunt placement.
- The authors judge benefit signals most consistent in spinal fusion and IIH, but adverse effects and database overlap limit causal inference, and they call for prospective trials.
- Meta-analysis of 22 RCTs including 4161 older surgical patients under general anesthesia, searched across PubMed, Embase and CENTRAL through July 2026.
- Compared perioperative intravenous dexmedetomidine with control for prevention of postoperative delirium, the primary outcome.
- Dexmedetomidine reduced postoperative delirium (RR 0.56, 95% CI 0.47 to 0.66; P<0.00001; I² 24%) and PONV (RR 0.79, 95% CI 0.62 to 0.99; P=0.04).
- Dexmedetomidine was associated with more intraoperative and postoperative bradycardia and more intraoperative hypotension.
- Systematic review and meta-analysis of 87 RCTs enrolling 30,611 adults undergoing surgical, endoscopic, or dental procedures.
- Compared pEEG-guided with non-pEEG-guided anesthesia on anesthetic drug use, postoperative delirium, and perioperative efficiency measures.
- pEEG reduced propofol use (SMD -0.42) and volatile agent use (SMD -1.27), and postoperative delirium risk fell (RR 0.73, 95% CI 0.63 to 0.84).
- Extubation, wake-up, orientation, and PACU stay were all shorter with pEEG, with BIS showing the most consistent benefit and substantial heterogeneity for several outcomes.
- Single-centre, double-blind randomised noninferiority trial of 686 adults having elective neurovascular surgery, analysed as a modified intention-to-treat population.
- Patients received remimazolam-based TIVA with flumazenil reversal at emergence or propofol-based TIVA, both with remifentanil.
- Postoperative delirium within 5 days occurred in 12.8% (44/344) with remimazolam and 10.8% (37/342) with propofol; risk difference 1.97 percentage points (95% CI -2.85 to 6.80).
- Remimazolam met the prespecified noninferiority criterion, and that group had less intraoperative hypotension below a MAP of 65 mm Hg and more operating-room extubation.
- Systematic review and meta-analysis of five randomized trials, totaling 1613 adults aged 60 or older having surgery under regional anesthesia.
- Compared intraoperative dexmedetomidine with propofol, with delirium assessed using CAM or CAM-ICU.
- Delirium occurred in 7.7% of dexmedetomidine patients versus 16.7% with propofol (RR 0.48, 95% CI 0.36-0.64; P < .001), with low heterogeneity (I² = 13.4%).
- The authors conclude dexmedetomidine is associated with less postoperative delirium, and they rated the certainty of evidence as moderate by GRADE.
- Systematic review and meta-analysis of seven retrospective cohorts (28,525 patients) comparing lumbar fusion patients with and without preoperative GLP-1RA exposure.
- Six of the seven studies used propensity score matching or another matching strategy to balance the comparison groups.
- No significant association with reoperation or revision (OR 0.74, 95% CI 0.44-1.24; P = 0.25) or postoperative infection (OR 0.83, 95% CI 0.68-1.00; P = 0.05).
- The authors found no signal of increased postoperative risk and called for prospective studies with standardized exposure definitions and perioperative management protocols.
- This structured narrative review synthesizes adult postoperative delirium evidence across the perioperative pathway, searching major databases plus ESAIC and ASA resources and reference lists.
- It classifies prevention and therapeutic strategies by clinical maturity, target population, and implementation readiness rather than by pooled effect size.
- The authors report that no single anesthetic technique, processed-EEG target, blood-pressure threshold, cerebral oximetry strategy, or agent consistently prevents delirium across surgical populations.
- Multicomponent non-pharmacological prevention has the most consistent support, dexmedetomidine appears context-dependent, and biomarkers and metabolic targets remain investigational.
- Systematic review and meta-analysis of 13 RCTs including 1446 patients comparing preoperative cognitive training with usual care.
- Primary outcomes were postoperative delirium, delayed neurocognitive recovery, and postoperative neurocognitive disorder.
- Training was associated with lower postoperative delirium risk (RR 0.53, 95% CI 0.36-0.77, P=0.001), though certainty was rated low.
- The delayed neurocognitive recovery reduction (RR 0.66, 95% CI 0.46-0.96) was not robust to sensitivity analyses, and traditional training may outperform digital training for delirium.
- Prospective exploratory observational study of 83 elderly patients from one tertiary hospital under sevoflurane anesthesia with 19-channel EEG, after 17 excluded for artifacts.
- Exposure was EEG alpha anteriorization and network efficiency across induction, maintenance, emergence, and PACU phases, compared between patients with and without postoperative delirium.
- Just before loss of responsiveness, nondelirium patients showed frontal alpha power of 4.24 vs -0.88 dB (P = .007), whereas delirium patients showed minimal change.
- During maintenance, the delirium group had longer averaged characteristic path lengths (4.49 ± 0.62 vs 3.57 ± 0.16, P = .026, FDR-corrected), suggesting reduced network efficiency.
- This mini review synthesizes a targeted search of pediatric esketamine studies covering analgesia, sedation, propofol injection pain, and emergence delirium or agitation.
- Randomized trials and meta-analyses generally report fewer emergence delirium or agitation events after low intravenous esketamine doses, mostly during sevoflurane adenotonsillectomy.
- Direct dose-comparison evidence in that setting shows increasing benefit up to 0.5 mg/kg intravenously, with no upper efficacy or safety boundary identified.
- The authors conclude that 0.2-0.5 mg/kg IV was the best-studied range for emergence prevention, not a validated therapeutic window, and call for direct dose-timing trials.
- Retrospective PearlDiver Mariner database study of patients with type 2 diabetes on metformin who underwent posterior cervical surgery from 2010 to 2023, using propensity-score matching.
- Preoperative GLP-1 receptor agonist users were compared with matched non-users and with patients who had prior bariatric surgery.
- GLP-1 users had lower odds of perioperative pneumonitis (OR 0.57; 95% CI 0.43-0.75; p<0.001) and of 90-day revision surgery (OR 0.33; 95% CI 0.29-0.36; p<0.001).
- Lower odds persisted for 2-year revision surgery and nutritional deficiency, and no significant differences were found versus the bariatric surgery cohort.
- Prospective cohort substudy of adults undergoing hip or knee arthroplasty, measuring plasma and CSF brain-derived tau before neuraxial anaesthesia and up to 48 h after surgery.
- Plasma brain-derived tau peaked at 4 h with a 254% rise (IQR 137-382%, P<0.001) and was still 31% above baseline at 48 h (6-75%, P<0.001).
- CSF brain-derived tau was unchanged at 4 h but rose 51% by 48 h (21-82%, P=0.004), and plasma and CSF levels were inversely associated (β=-0.71, P<0.001).
- The authors suggest the early plasma rise reflects redistribution of tau from the CNS rather than concomitant neuronal injury; higher plasma levels were also associated with worse cognition at 3 months.
- Meta-analysis of 25 randomized controlled trials (3344 patients) comparing perioperative ketamine or esketamine with placebo or standard care for postoperative delirium.
- Ketamine (9 trials) and esketamine (16 trials) were compared with control, with subgroup analyses by dose, regimen, surgery type and timing of assessment.
- Both agents reduced postoperative delirium risk: ketamine RR 0.69 (95% CI 0.49-0.98, P = .04) and esketamine RR 0.58 (95% CI 0.36-0.95, P = .03).
- Dizziness risk rose (RR 1.45, 95% CI 1.14-1.84), and trial sequential analysis found the evidence inconclusive, so the authors call for large multicenter RCTs.
- Systematic review and meta-analysis of 13 randomized trials including 3,861 adult ICU patients, comparing open or flexible family visiting with restricted visiting.
- Delirium was the primary outcome; secondary outcomes were invasive ventilation duration, ICU length of stay, hospital-acquired infections, and ICU mortality.
- Open or flexible presence reduced delirium (RR 0.48; 95% CI 0.29-0.81; low certainty) and invasive ventilation duration (MD -0.36 d; 95% CI -0.46 to -0.26 d; low certainty).
- No effect was seen on ICU length of stay, infections, or ICU mortality; the authors note low certainty of evidence and substantial heterogeneity.
- Retrospective cohort of 1907 adults having a first intracranial operation in the INSPIRE database (2011-2020), with PaCO₂ drawn within 60 minutes and paired ETCO₂.
- The exposure was the first-hour arterial-to-end-tidal CO₂ gradient, examined against database-recorded all-cause death within 90 days.
- A larger gradient was associated with mortality, with an OR of 1.38 per 5 mmHg (95% CI 1.09-1.73) and 1.34 (95% CI 1.06-1.69) in the revised model with 92 events.
- Adding the gradient barely changed optimism-corrected AUC (0.832 to 0.833) and did not improve the Brier score, and neither component was shown to predominate.
AI summary not available. Read the source abstract on PubMed.
- Pragmatic randomized trial at Mount Sinai Hospital including 7294 surgical patients with preoperative cognitive impairment identified by NLP, MMSE scores, or diagnostic codes.
- Patients were randomized to an AI-driven, non-interruptive EHR decision support tool aimed at anesthesia team adherence, or to routine perioperative care.
- Only 1255 patients (17.2%) had documented delirium assessments; delirium occurred in 35.1% of intervention and 32.7% of control patients (P = .37).
- Best practice adherence did not differ significantly between groups (all P > .05), and the authors call for further work on using these tools effectively.
- Randomized trial of 178 analyzed patients undergoing posterior lumbar interbody fusion, comparing deep and moderate neuromuscular blockade.
- Deep neuromuscular blockade was compared with moderate blockade, with 3-month chronic postsurgical pain incidence as the primary outcome.
- Chronic pain at 3 months was 19.1% with deep block vs 34.8% with moderate block (RR 0.6; 95% CI 0.3-0.9; P = .018), with no significant difference at 6 months (RR 0.8; 95% CI 0.4-1.5; P = .423).
- Deep block was linked to lower CK, myoglobin and LDH on day 1 and better paraspinal muscle preservation on 6-month MRI; authors attribute benefit to less muscle injury.
AI summary not available. Read the source abstract on PubMed.
- Prospective multicenter trial of 50 enrolled patients with chronic back and/or leg pain after lumbar spine surgery, of whom 32 completed 12-month activity follow-up.
- Baseline mobility was recorded with an accelerometer-equipped external stimulator, and permanent spinal cord stimulation followed if patients achieved at least 50% pain relief on trial.
- Mobility episodes of at least 30 seconds were 34±27 min/24 hours at baseline versus 92±51 min in healthy controls (p=0.009), and rose significantly only by 12 months (p=0.045).
- The increase was significant in leg-predominant pain (35±27 to 54±32 min, p=0.011) but not back-predominant pain, and mobility correlated with reduced disability (p=0.044) and leg pain (p=0.046).
- Single-center retrospective before-and-after cohort of 86 children after congenital heart surgery with cardiopulmonary bypass, mechanically ventilated over 24 hours, in a tertiary pediatric cardiac ICU.
- Compared an institutional sedation protocol before versus after adding enteral chloral hydrate as an adjunctive sedative.
- Cumulative midazolam exposure was lower with chloral hydrate (10.2 vs 13.2 mg/kg, p = 0.010), and observed delirium was lower (14.6% vs 37.8%, p = 0.015).
- Sedation quality, pain scores, withdrawal, ventilation duration, length of stay, and mortality did not differ significantly; the authors call for prospective multicenter confirmation.
- This delirium-focused secondary analysis of a single-centre, double-blind, placebo-controlled trial enrolled adults having head and neck cancer surgery with free-flap reconstruction.
- Patients received intraoperative dexmedetomidine at 0.3 μg/kg/h until 1 hour before surgery ended, or comparable volumes of saline placebo.
- Delirium over the first 5 postoperative days occurred in 14.9% (7/47) of dexmedetomidine patients versus 34.7% (17/49) of placebo patients (adjusted OR 0.31, 95% CI 0.10-0.92; p = 0.036).
- Pain and early sleep were reported as improved with dexmedetomidine, and haemodynamic adverse events and postoperative complications did not differ significantly between groups.
AI summary not available. Read the source abstract on PubMed.
- Propensity-matched retrospective cohort using TriNetX electronic health records of adults undergoing lumbar spine surgery from 2010 to 2024, with 53,639 opioid-naive and 2031 OUD patients analyzed.
- Exposure was intraoperative ketamine, analyzed separately in opioid-naive patients and those with opioid-use disorder.
- Ketamine was linked to more outpatient opioid prescribing in opioid-naive patients at 48 hours (RR 1.23, 95% CI 1.22-1.25) and 6 weeks (RR 1.14, 95% CI 1.10-1.18).
- Adverse events and new OUD diagnoses were not reduced and were similar or higher with ketamine, so the authors found no detectable population-level opioid-sparing signal.
- This study combined a human cohort of post-traumatic headache patients without prior aura with a mouse model of mild TBI, using electrophysiology, neuroimaging, and behavioral assays.
- Mice received closed-head mTBI, and separately onabotulinumtoxinA was given subcutaneously to the scalp after injury, with optogenetically evoked CSD used to probe pain behavior.
- In humans, 35 of 108 patients (32%) developed new aura within 60 days, and injured mice showed a 160% increase in CSD induction probability.
- OnabotulinumtoxinA did not change CSD susceptibility but completely abolished optogenetic CSD-induced allodynia, which the authors suggest may help treat PTH with aura.
- Systematic review and meta-analysis of 17 RCTs (N=2288) comparing NIRS-guided with usual-care intraoperative management in adults undergoing on-pump cardiac surgery.
- Outcomes assessed included postoperative cognitive decline, delirium, stroke, mortality and functional recovery.
- NIRS guidance probably reduced early postoperative cognitive decline (RR 0.65, 95% CI 0.42-0.99; moderate certainty).
- Effects on stroke, mortality and delirium were imprecise with low certainty, and no included trial measured validated quality of life or function.
- Prospective proof-of-concept cohort of 84 adults aged 65 or older awaiting elective noncardiac surgery, tested remotely with Cogstate from preoperatively to 12 months.
- An interrupted time-series analysis compared cognitive trajectories before and after surgery, accounting for preoperative trends rather than a single baseline.
- Surgery was associated with a small decline in psychomotor and attention level (p = 0.017), and postoperative trajectories improved versus preoperative in psychomotor (p = 0.008), attention (p = 0.002), and visual learning (p = 0.007).
- After adjusting for confounders, only the postoperative level change in attention remained significant (p = 0.027), and the authors call the findings exploratory and in need of adequately powered confirmation.
- Pragmatic, open-label, multicenter randomized trial of 2508 adults aged 50 or older having elective major noncardiac surgery at 49 UK NHS hospitals.
- Patients were randomized 1:1 to maintenance of general anesthesia with propofol TIVA or volatile inhalational agents, with other perioperative care left to clinician discretion.
- Days alive and at home at 30 days were similar (22.5 vs 22.4 days; incidence rate ratio 1.00, 95% CI 0.99-1.02; adjusted P = .68).
- TIVA was associated with lower reported thirst, hoarseness, and nausea/vomiting; major complications (12.4% overall) did not differ between groups.
- Retrospective population-based cohort of 1204 adults aged 66 or older in Ontario, Canada (2009-2021), who survived a first TBI admission and started a new antipsychotic within 30 days of discharge.
- Compared new haloperidol or risperidone prescriptions against quetiapine for risk of new epilepsy diagnosis over up to 5 years, using inverse probability of treatment weighting with cause-specific Cox models.
- Haloperidol was not associated with higher epilepsy risk (aHR 0.73; 95% CI 0.39-1.34), and risperidone was not either (aHR 0.94; 95% CI 0.65-1.36) compared with quetiapine.
- Authors found no clear signal of differential epilepsy risk, but note high mortality limited comparability across groups, CIs were wide, and confirmatory studies are needed.
- Prospective observational pilot study of 30 adults undergoing elective coronary artery bypass grafting at a single university hospital.
- Modified passive leg raising was performed at three intraoperative time points, with pressure-based dynamic preload indices compared against echocardiographic flow velocity variations.
- Stroke volume variation fell from 13% ± 4% to 10% ± 4% and pulse pressure variation from 10% ± 2% to 7% ± 3% (both p < 0.05); pressure- and flow-derived indices correlated weakly (r = 0.147-0.351).
- Authors concluded that pressure-derived indices correlated only weakly with echocardiographic respiratory peak velocity variations, and the physiological meaning of these correlations remains uncertain since forward flow did not measurably increase.